Bain Capital Public Equity Management’s Regenxbio RGNX Stock Holding History

Bain Capital Public Equity Management’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-720,927	Closed	-$23.8M	–	102
2017 Q3	$23.8M	Sell	720,927 -1,039,034	-59%	-$23.4M	1.5%	23
2017 Q2	$34.8M	Sell	1,759,961 -133,350	-7%	-$2.58M	2.09%	17
2017 Q1	$36.5M	Sell	1,893,311 -601,048	-24%	-$11.6M	2.59%	18
2016 Q4	$46.3M	Buy	2,494,359 +22,272	+0.9%	+$426K	3.14%	12
2016 Q3	$34.6M	Buy	2,472,087 +543,320	+28%	+$6M	2.25%	18
2016 Q2	$15.4M	Hold	1,928,767	–	–	0.65%	30
2016 Q1	$20.8M	Sell	1,928,767 -6,194	-0.3%	-$79.3K	0.77%	26
2015 Q4	$32.1M	Hold	1,934,961	–	–	0.92%	31
2015 Q3	$42.6M	Buy	+1,934,961	New	+$49.4M	1.27%	27

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Bain Capital Public Equity Management's RGNX Position: Q4 2017 in Review

Bain Capital Public Equity Management sold out of Regenxbio (RGNX) in Q4 2017, closing a stake of 720,927 shares — an estimated $23.8M sold.

Bain Capital Public Equity Management first reported a position in RGNX in Q3 2015 and held it in 9 quarters. The position peaked at $46.3M in Q4 2016. 108 funds tracked by Wall St. Rank hold RGNX as of Q4 2017.

Bain Capital Public Equity Management reported no remaining Regenxbio position as of Q4 2017 after selling out during the quarter.
Bain Capital Public Equity Management sold 720,927 Regenxbio shares in Q4 2017, an estimated $23.8M.
Bain Capital Public Equity Management first reported a position in Regenxbio in Q3 2015 and held it in 9 quarters.
Bain Capital Public Equity Management's Regenxbio position peaked at $46.3M in Q4 2016.
108 funds tracked by Wall St. Rank held Regenxbio as of Q4 2017.

Based on Bain Capital Public Equity Management's 13F filing for Q4 2017, filed 14 Feb 2018.